Effects of Diabetes on Pregnancy in EARLY PREGNANCY
Effects of Diabetes on Pregnancy in LATE PREGNANCY
Effects of Diabetes on Pregnancy in during Birth
Effects of Diabetes on Pregnancy in the Postpartum Period
Maternal Effects of Pre-Existing Diabetes TYPE 1
Increased Maternal risks due to Diabetes Mellitus on Pregnancy
Fetal and neonatal adverse effects of Diabetes Mellitus in Pregnancy
Therapeutic Management of Diabetes
Laboratory test for a pregnant woman with Diabetes
The goals of therapeutic management for a pregnant woman with diabetes are to
(1) maintain normal blood glucose levels
(2) facilitate the birth of a healthy baby, and
(3) avoid accelerated impairment of blood vessels and other major organs. To achieve this outcome, an intensive, team approach to care is required.
Maternal adverse effects of gestational diabetes
Risk Factors for Gestational Diabetes Mellitus
Screening for Gestational Diabetes Mellitus
Glucose Challenge Test.
- A GCT is administered between 24 and 28 weeks of gestation, often to both low- and high-risk antepartum patients.
- . Fasting is not necessary for a GCT, and the woman is not required to follow any pretest dietary instructions.
- STEPS: The woman should ingest 50 g of oral glucose solution. A blood sample is taken 1 hour later. If the blood
glucose concentration is 140 mg/dL or greater, a 3-hour oral glucose tolerance test is recommended.
Oral Glucose Challenge Test.
- An oral glucose tolerance test (OGTT) may be used as the initial test if a woman is at high risk for GDM, but the test
is more likely to be used for diagnosis following abnormally high GCT results
- OGTT is the gold standard for diagnosing diabetes, but it is a more complex test.
- The woman must fast from midnight on the day of the test. After a fasting plasma glucose level is determined, the
woman should ingest 100 g of oral glucose solution. Plasma glucose levels are then determined at 1, 2, and 3
hours.
* GDM is the diagnosis if the fasting blood glucose level is abnormal or if two or more of the following values occur on the OGTT
• Fasting, greater than 95 mg/dL
• 1 hour, greater than 180 mg/dL
• 2 hours, greater than 155 mg/dL
• 3 hours, greater than 140 mg/dL
Signs and symptoms of maternal HYPOglycemia include:
Signs and symptoms of maternal hyperglycemia include the following:
Managing HYPOglycemia
*****If untreated, hypoglycemia can progress to convulsions and death. To prevent hypoglycemia, instruct the woman to have meals at a fixed time each day and to plan snacks at 10 am, 3 pm, and bedtime. Suggest that she always carry glucose tablets or gel or some crackers with her.
Managing HYPERglycemia
Congenital Heart Diseae
Atrial Septal Defect - Pulmonary hypertension occasionally develops in uncorrected atrial septal defects because the additional blood that moves to the right side of the heart is transported to the lungs through the pulmonary artery
Ventricular Septal Defect - Bacterial endocarditis is common with unrepaired defects, and antibacterial prophylaxis is recommended
Patent Ductus Arteriosus. - The patent ductus arteriosus tends to become infected, so antibiotic prophylaxis before labor is recommended
Mitral Valve Prolapse. Mitral valve prolapse is one of the most common cardiac conditions among the general population. In mitral valve prolapse, the leaflets of the mitral valve prolapse into the left atrium during ventricular contraction.Some physicians consider mitral valve prolapse to be a significant risk factor for bacterial endocarditis and administer prophylactic antibiotics before and during labor and delivery. Beta-blockers such as atenolol
Rheumatic Heart Disease
Rheumatic heart disease is a complication that sometimes follows streptococcal pharyngitis (“strep throat”). Even one bout of rheumatic fever may cause scarring of the heart valves, resulting in stenosis (narrowing) of the openings between the chambers of the heart.
Signs and Symptoms of Heart Disease
Therapeutic Management for Class I or II Heart Disease
Therapeutic Management for Class III or IV Heart Disease
The PRIMARY goal of management is to prevent cardiac decompensation and development of CHF.
Drug therapy for Heart Disease in Pregnant women
Anticoagulants. During pregnancy, clotting factors normally increase and thrombolytic activity decreases. These changes predispose the pregnant woman to thrombus formation.
- Warfarin (Coumadin) is associated with fetal malformations and should be restricted throughout pregnancy.
* *** Postpartum anticoagulation is continued with warfarin
- Subcutaneous heparin, which does not cross the placental barrier, is an effective alternative anticoagulant for most.
* ******Heparin is withheld during labor & resumed 6 hs after vaginal birth and 18 - 24 hrs after cesarean
- Enoxaparin (Lovenox), a LMWH, may be used instead of standard heparin because it requires less-frequent monitoring for bleeding complications.
* **** Enoxaparin and heparin are not interchangeable. Both are given subcutaneously, but only heparin may be given intravenously.Antidysrhythmics
- In addition to controlling the dysrhythmias, beta-blockers and calcium channel blockers may be used to control
maternal hypertension.
- Digoxin, adenosine, and calcium channel blockers appear to be safe.
Drug therapy for Heart Disease in Pregnant women
Anticoagulants. During pregnancy, clotting factors normally increase and thrombolytic activity decreases. These changes predispose the pregnant woman to thrombus formation.
- Warfarin (Coumadin) is associated with fetal malformations and should be restricted throughout pregnancy.
** Postpartum anticoagulation is continued with warfarin
- Subcutaneous heparin, which does not cross the placental barrier, is an effective alternative anticoagulant for most.
**Heparin is withheld during labor & resumed 6 hs after vaginal birth and 18 - 24 hrs after cesarean
- Enoxaparin (Lovenox), a LMWH, may be used instead of standard heparin because it requires less-frequent monitoring for
Bleeding complications.
** Enoxaparin and heparin are not interchangeable. Both are given subcutaneously, but only heparin may be given intravenously.
Antidysrhythmics
- Digoxin, adenosine, and calcium channel blockers appear to be safe.
- Beta-blockers have been associated with neonatal respiratory depression, sustained bradycardia, and
hypoglycemia when administered late in pregnancy or just before delivery but may be needed in selected cases.
- The beta-blockers atenolol and metoprolol may be preferred because they do not cause the uterine stimulation
that other drugs of this class may cause
Antiinfectives.
- A woman with an increased risk for bacterial endocarditis may receive prophylactic antibiotics such as amoxicillin,
penicillin, ampicillin, and gentamicin at delivery.
- Ceftriaxone or vancomycin also may be given for acute endocarditis.
Diuretics - Drugs for heart failure
- Carefully monitor electrolytes and water balance to avoid adverse effects on mother and fetus
- IUGR has been associated with furosemide, and neonatal jaundice, thrombocytopenia, anemia, and hypoglycemia
have been associated with thiazide diuretics